(12) United States Patent (10) Patent No.: US 9,096,585 B2 Shaw Et Al
US009096585B2 (12) United States Patent (10) Patent No.: US 9,096,585 B2 Shaw et al. (45) Date of Patent: Aug. 4, 2015 (54) ANTIVIRAL COMPOUNDS AND USES (2013.01); C07D 413/10 (2013.01); C07D THEREOF 413/12 (2013.01); A61 K 3 1/5377 (2013.01); A61 K3I/55 (2013.01) (75) Inventors: Megan Shaw, New York, NY (US); (58) Field of Classification Search Hans-Heinrich Hoffmann, New York, CPC. A61K 31/4245; A61K31/5377; A61K31/55 NY (US); Adolfo Garcia-Sastre, New USPC .................................... 514/364, 217.1, 236.2 York, NY (US); Peter Palese, Leonia, NJ See application file for complete search history. US (US) (56) References Cited (73) Assignee: Icahn School of Medicine at Mount Sinai, New York, NY (US) U.S. PATENT DOCUMENTS 6,384,064 B2 5, 2002 Camden (*) Notice: Subject to any disclaimer, the term of this 8,278,342 B2 10/2012 Ricciardi patent is extended or adjusted under 35 Continued U.S.C. 154(b) by 210 days. (Continued) (21) Appl. No.: 13? 700,049 FOREIGN PATENT DOCUMENTS y x- - - 9 (22) PCT Filed1C Mavay 31,51, 2011 WO WO 2009,136979 A2 11/2009 OTHER PUBLICATIONS (86). PCT No.: PCT/US2011/038515 Chu et al. "Analysis of the endocytic pathway mediating the infec S371 (c)(1), tious entry of mosquito-borne flavivirus West Nile into Aedes (2), (4) Date: Feb. 14, 2013 albopictus mosquito (C6/36) cells.” Virology, 2006, vol. 349, pp. 463-475. (87) PCT Pub. No.: WO2011/150413 (Continued) PCT Pub. Date: Dec. 1, 2011 Primary Examiner — Shengjun Wang (65) Prior Publication Data (74) Attorney, Agent, or Firm — Jones Day US 2013/O137678A1 May 30, 2013 (57) ABSTRACT O O Described herein are Compounds, compositions comprising Related U.S.
[Show full text]